{
    "organizations": [],
    "uuid": "00381b5b22a7712550862346f14ef53c7335c927",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eyegate-pharmaceuticals-posts-q1-r/brief-eyegate-pharmaceuticals-posts-q1-revenue-of-1-096-million-idUSASC0A1S6",
    "ord_in_thread": 0,
    "title": "BRIEF-Eyegate Pharmaceuticals Posts Q1 Revenue Of $1.096 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 11 (Reuters) - EyeGate Pharmaceuticals Inc:\n* EYEGATE PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* Q1 REVENUE $1.096 MILLION VERSUS $185,000 * NET LOSS IN Q1 OF 2018 WAS $2.38 MILLION, COMPARED WITH $2.92 MILLION IN Q1 OF 2017 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-11T20:35:00.000+03:00",
    "crawled": "2018-05-12T17:29:07.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "eyegate",
        "pharmaceutical",
        "inc",
        "eyegate",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "q1",
        "revenue",
        "million",
        "versus",
        "net",
        "loss",
        "q1",
        "million",
        "compared",
        "million",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}